# US 2022/0031201 A1 · Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031201 A1
- Document ID: US20220031201A1
- Status: Published application
- Kind: A1
- Application number: 17/503,327
- Filed: 2021-10-17
- Published: 2022-02-03
- Earliest claimed: 2008-03-25
- Assignees: St. Louis Medical Devices, Inc.
- Applicants: St. Louis Medical Devices, Inc.
- Inventors: Zhi Xu
- Web page: https://patentgrep.com/patent/US20220031201A1

## CPC

- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method and system for detecting glucose in a biological sample is disclosed. This includes illuminating a biological sample with a light source, collecting transmitted, transflected or reflected light from the sample with a detector, generating spectral data of one or more components in the sample other than glucose in a spectral data analysis device, and analyzing the spectral data of the one or more components, sufficient to provide a glucose measurement from the spectral data of the one or more components other than glucose with the spectral data analysis device.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A method for measuring a blood glucose concentration comprising:
a) illuminating a biological sample with a light beam from a light generating device; and
b) receiving and analyzing an induced change of a light signal of one or more non-blood glucose components from the sample with a detector,
wherein the induced change of the light signal is caused by physical or chemical interaction of glucose with the one or more non-blood glucose components;
wherein the analyzing of the induced change of the light signal comprises:
generating spectral data, having peaks and valleys, of the one or more non-blood glucose components;
analyzing spectral data of the one or more blood components, wherein the one or more blood components are non-blood glucose;
wherein light absorption measured of the one or more non-blood glucose components contains a change of an absorption amount that is induced by an amount of a presence of the blood glucose which is used indirectly determine the concentration of the blood glucose.

### Claim 23 (depends on 22)

The method of claim 22, wherein the light generating device comprises a Laser, a light emitting diode (LED), an incandescent lamp, a halogen lamp or a combination thereof.

### Claim 24 (depends on 22)

The method of claim 22, further comprising eliminating light signal data of the one or more non-blood glucose components for changes in absorbance not related to interactions with the glucose.

### Claim 25 (depends on 22)

The method of claim 22, further comprising forming a Visible or NIR spectra using the light signal.

### Claim 26 (depends on 22)

The method of claim 22, wherein the measurement of the light absorption excludes an interference of a measurement by fat, muscle and interstitial fluid.

### Claim 27

A blood glucose concentration measuring device comprising:
a) a light generating device configured to illuminate a biological sample with a light beam; and
b) a programmable computing device comprising light photocurrent sensors configured to receive and analyze an induced change of a light signal of one or more non-blood glucose components from the sample with a detector,
wherein the induced change of the light signal is caused by the physical or chemical interaction of glucose with the one or more non-blood glucose components;
wherein the programmable computing device analyzes the induced change of the light signal by:
generating spectral data, having peaks and valleys, of the one or more non-blood glucose components;
analyzing spectral data of the one or more blood components, wherein the one or more blood components are non-blood glucose;
wherein light absorption measured of the one or more non-blood glucose components contains a change of an absorption amount that is induced by an amount of a presence of the blood glucose which is used to indirectly determine the concentration of the blood glucose.

### Claim 28 (depends on 27)

The device of claim 27, wherein the light generating device comprises a Laser, a light emitting diode (LED), an incandescent lamp, a halogen lamp or a combination thereof.

### Claim 29 (depends on 27)

The device of claim 27, wherein the programmable computing device is configured to eliminate the light signal data of the one or more non-blood glucose components for changes in absorbance not related to interactions with the glucose.

### Claim 30 (depends on 27)

The device of claim 27, wherein the programmable computing device is configured to form a Visible or NIR spectra using the light signal.

### Claim 31 (depends on 27)

The device of claim 27, wherein the programmable computing device is configured to avoid analyzing light signal of glucose.

### Claim 32 (depends on 27)

The device of claim 27, wherein the measurement of the light absorption excludes an interference of a measurement by fat, muscle and interstitial fluid.

### Claim 33

A system for detecting blood glucose in a biological sample, comprising:
a) a light generating device configured to illuminate a biological sample comprising a plurality of blood components;
b) a detector configured to collect transmitted, transflected or reflected light from the biological sample; and
c) a computing device configured to:
generate spectral data, having peaks and valleys, of the one or more non-blood glucose components;
analyze spectral data of the one or more blood components, wherein the one or more blood components are non-blood glucose;
wherein light absorption measured of the one or more non-blood glucose components contains a change of an absorption amount that is induced by an amount of a presence of the blood glucose which is used to indirectly determine the concentration of the blood glucose.

### Claim 34 (depends on 33)

The system of claim 33, wherein the light generating device comprises lasers, light emitting diodes, halogen lamps, incandescent lamps or a combination thereof.

### Claim 35 (depends on 33)

The system of claim 33, wherein the light generating device is configured to emit light in at least one of near infrared, mid-infrared and visible light regions.

### Claim 36 (depends on 33)

The system of claim 33, wherein the light generating device is configured to emit light having a wavelength in a range of 400 nm to 2500 nm.

### Claim 37 (depends on 33)

The system of claim 33, wherein the computing device is configured to mathematically compare changes in absorbance of the one or more blood components to changes in blood glucose concentration.

### Claim 38 (depends on 33)

The system of claim 33, wherein the computing device is configured to eliminate portions of the spectral data that are attributable to changes in absorbance not related to interactions with blood glucose.

### Claim 39 (depends on 33)

The system of claim 33, wherein the biological sample comprises a portion of at least one of a human finger, toe, ear lobe, tongue or arm.
